Japan’s Ministry Expands iPS Patent Support To Facilities Nationwide
This article was originally published in PharmAsia News
Japan's Ministry of Education, Culture, Sports, Science and Technology plans to expand support measures for research facilities and help them obtain patents for induced pluripotent stem cell research. Besides previously announced research facilities such as Kyodo University, MEXT's support will expand to all universities and research institutes who are conducting iPS research. The measures include recruiting patent experts who are familiar with U.S. and Europe patent systems to conduct research on overseas' iPS patent protection. The experts will provide consultancy to domestic institutions in obtaining overseas patents. (Click here for more - Japanese language
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.